Magnolia Medical Technologies
Focus: Magnolia Medical Technologies is a 5,000+ employee biotech company headquartered in Seattle specializing in sepsis diagnosis devices, particularly blood culture contamination prevention.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Employees
5000+
Open Jobs
5
Should You Work at Magnolia Medical Technologies?
AI assessmentConsider only if seeking a stable, established device company role with modest growth prospects; high information asymmetry makes full career risk assessment difficult.
Why Work Here
- Focused portfolio in high-need infectious disease space (sepsis diagnosis) with clear clinical utility
- Established scale (5,000+ employees) suggests operational maturity and stable infrastructure
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Stable
Growth
Lead commercial product addressing a significant source of false-positive sepsis diagnoses and unnecessary antibiotic use.
Pipeline & Clinical Trials
Help build intelligence for Magnolia Medical Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.